Search Results

1 January 1970

Posted by: Richard Scrase

Category: News

Results

New antibody protects monkeys from deadly Hendra virus

Squamous cell skin carcinoma is the second most common skin cancer after melanomas, affecting approximately 10,000 people in the UK each year.
A new antibody treatment protects monkeys from the deadly Hendra virus. It is the first medicine to be developed to treat the virus which kills over half the humans it infects.… http://www.understandinganimalresearch.org.uk/news/research-medical-benefits/new-antibody-protects-monkeys-from-deadly-hendra-virus/

Potential treatment for terminal cancer

For the first time, researchers have discovered a therapy that can treat the invariably lethal terminal stages of cancer in animals.
For the first time, researchers have discovered a therapy that can treat the invariably lethal terminal stages of cancer in animals. The new monoclonal antibody is effective in… http://www.understandinganimalresearch.org.uk/news/research-medical-benefits/potential-treatment-for-terminal-cancer/

Sticky antibodies prevent onset of vCJD

Antibodies able to bind to a protein in the brain show promise in mice for preventing fatal prion diseases like vCJD (variant Creutzfeldt-Jakob Disease).
Antibodies able to bind to a protein in the brain show promise in mice for preventing fatal prion diseases like vCJD (variant Creutzfeldt-Jakob Disease). vCJD is a progressive… http://www.understandinganimalresearch.org.uk/news/research-medical-benefits/sticky-antibodies-prevent-onset-of-vcjd/

Last edited: 19 September 2014 04:49